Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test

Content provided by APO Group. CNBC Africa provides content from APO Group as a service to its readers, but does not edit the articles it publishes. CNBC Africa is not responsible for the content provided by APO Group.

WHO Prequalification approval allows Abbott (www.Abbott.com) to bring critical technology to more resource-limited settings; confirms that the m-PIMA™ HIV-1/2 VL meets global standards of quality, safety and efficacy

Abbott announced today that m-PIMA™ HIV-1/2 VL (https://abbo.tt/2IUTDwL), the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The test received CE Mark in December 2018.

“m-PIMA HIV-1/2 VL is the only truly portable molecular point-of-care test designed specifically for use in resource-limited settings such as in sub-Saharan Africa,” said Damian Halloran, vice president, Infectious Disease – Emerging Markets, Rapid Diagnostics, Abbott. “With WHO PQ, global funders and ministries of health can now confidently expand access to viral load testing, reaching more people who need the test, with the most compact and efficient point-of-care HIV diagnostic platform available anywhere in the world today.”

To provide the most effective HIV treatment and care, the WHO recommends that everyone receiving antiretroviral therapy (ART) undergoes a viral load test at 6 months and 12 months, and annually thereafter, if the individual is stable on ART. Viral load testing is the gold standard for monitoring ART treatment failure. Unfortunately, very few people in resource-limited settings, such as select countries in sub-Saharan Africa, Asia and Latin America, have access to the necessary level of care.

Abbott’s m-PIMA HIV-1/2 VL is a quantitative nucleic acid amplification test for viral load measurement of HIV type 1 groups M/N and O, and HIV-2 in plasma samples. The platform is portable so it can be brought into the most remote locations. It’s easy to use, deployable at the point of care and designed to measure viral load in under 70 minutes, while the patient is still present. This allows people to receive results during the same visit and enables immediate treatment decisions, thereby reducing the number of people lost to follow-up. The test’s quick turnaround time is particularly valuable for monitoring the viral load of HIV-positive pregnant women and in cases of suspected HIV treatment failure.

The m-PIMA HIV-1/2 VL is part of Abbott’s comprehensive portfolio of diagnostic solutions for HIV screening, monitoring and viral load management. From the core lab to the point of care, Abbott provides critical tools to help healthcare providers make informed treatment decisions for people living with HIV.

About WHO Prequalification (PQ)

WHO Prequalification (PQ) aims to ensure that diagnostics, medicines, vaccines and immunization-related equipment and devices for high burden diseases meet global standards of quality, safety and efficacy, to optimize use of health resources and improve health outcomes.

The prequalification process consists of a transparent, scientifically sound assessment, which includes dossier review, consistency testing or performance evaluation and site visits to manufacturers. This information, in conjunction with other procurement criteria, is used by UN and other procurement agencies to make purchasing decisions regarding diagnostics, medicines and/or vaccines.

For more information, go to www.WHO.int/Topics/Prequalification/en/.

Distributed by APO Group on behalf of Abbott.

Media Contact: Abbott Media: Jackie Lustig Phone: +1 (781) 314-4009 John Koval Phone: +1 (954) 967-5022

Abbott Financial: Lukas Szot Phone: +1 (224) 667-2299

About Abbott: Abbott (www.Abbott.com) is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries.

Connect with us at www.Abbott.com, on Facebook at www.Facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.

Roberts, T., Cohn, J., Bonner, K., & Hargreaves, S. (2016). Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 62(8), 1043-1048. http://bit.ly/2J9wEgV UNAIDS (2014) 90-90-90 An ambitious target to help end the AIDS epidemic. Available on http://bit.ly/2GUAY0E

Media filesDownload logo

Related Content

L’Oreal’s Hlengiwe Mathenjwa on how Covid-19 has impacted the beauty & skincare industry

The 111 year old French beauty giant L’Oreal has appointed Hlengiwe Mathenjwa as the new director of its largest manufacturing facility in the Africa and Middle East region. This appointment comes amid the Covid-19 storm that is ravishing most industries globally, Hlengiwe Mathenjwa joins CNBC Africa for more.

COVID-19: Rwandan bound containers held at Mombasa port

Over 2000 Rwanda bound containers of goods have been held in Kenya and Tanzania due to the delays in cargo clearance. According to Rwanda's Private Sector Federation, the move contradicts a comprehensive regional COVID-19 approach that was agreed on in dealing with the challenges of the virus on the cross-border businesses between member states. Economic Analyst, Ted Kaberuka joins CNBC Africa for more.

Atlas Mara’s Maurice Toroitich on the major drivers behind strong Q1 results

A more efficient approach, frugal is what some experts have called it, now that is the strategy taken by BPR Atlas Mara Rwanda Managing Director, Maurice Toroitich and it seems to be reaping results, well at least in the short run. He joins CNBC Africa for a look at the bank’s first quarter results.

Omnia delivers solid results from a stabilised business

South Africa's biggest fertilizer producer Omnia was profitable in the year to March after extensively restructuring its business units. Omnia CEO, Seelan Gobalsamy joins CNBC Africa to breakdown the results.

Subscribe to our newsletter

Sign up for free newsletters and get more CNBC AFRICA delivered to your inbox

More from CNBC Africa

Uganda Securities Exchange CEO on how COVID-19 is impacting the bourse

The economic turmoil caused by the COVID-19 pandemic has had wide severe impact on financial markets not leaving behind stocks, bond and commodity markets. Uganda Securities Exchange CEO, Paul Bwiso joins CNBC Africa for more.

COVID-19: How the pandemic is accelerating the digitalization of healthcare

The COVID-19 pandemic has caused huge disruptions in healthcare provision, highlighting the need to adopt and invest in digitalization. Dr. Wanjeri Millicent Loice, Director and Content Manager, Toto Health Kenya joins CNBC Africa for more.

AfDB’s Nnenna Nwabufo on how COVID-19 has impacted African economies

According to the African Development Bank’s revised African Economic Outlook, though the continent is expected to rebound next year; it could lose a quarter of a trillion dollars in economic output for the rest of this year and 2021. Nnenna Nwabufo, Acting Director-General of East Africa Regional Office at the AfDB joins CNBC Africa for more.

Kenyan sports minister Amina Mohamed to bid for top WTO job

The Geneva-based body is seeking a replacement for Brazil’s Roberto Azevedo who is stepping down a year early at the end of August at a critical juncture for the trade watchdog.

Partner Content

Maktech’s Godwin Makyao: Now Is A Time of Entrepreneurial Opportunity in East Africa

As an executive decision-maker in both the telecommunications and tourism industries, Godwin Makyao could not have experienced a more diverse set of...

Sanlam launches urgent job-preservation initiative in response to COVID-19

Sanlam Investments is responding to the COVID-19 pandemic through large-scale support of the recovery of South African companies, from small enterprises to...

Trending Now

Steinhoff agrees to sell stake in Conforama France to Mobilux

JOHANNESBURG (Reuters) - Scandal-hit Steinhoff International agreed to sell its shares in furniture retailer Conforama France to Mobilux Sàrl, the parent company...

Namibia to ground national carrier’s license over cash hole

WINDHOEK (Reuters) - Cash-strapped Air Namibia will have its planes grounded at midnight on Wednesday after it failed to secure enough funding...

Uganda growth to sink as low as 0.4% this year – World Bank

KAMPALA (Reuters) - Ugandan economic growth is set to plunge to as low as 0.4% in 2020 from 5.6% last year as...

How retirement funds can contribute to rebuilding SA’s economy

Sanlam Benchmark Symposium: Sanlam has conducted research across a wide breadth of employers, retirement funds and professional consultants to benchmark their employee benefits experiences of the lock-down as well as their expectations of the future in a COVID-19 impacted economy. Chris Bishop spoke to Viresh Maharaj, Managing Executive, Sanlam Corporate Distribution, about the outcomes of the research and current trends in the Industry....
- Advertisement -